Identification of Candidate Drugs and Molecular Pathways for Pulmonary Arterial Hypertension and Chronic Kidney Disease-Reference-Cited by-同舟云学术

Identification of Candidate Drugs and Molecular Pathways for Pulmonary Arterial Hypertension and Chronic Kidney Disease

Published:2023-12-09 Issue: Volume:52 Page:1-5
ISSN:
Container-title:2023 5th International Conference on Sustainable Technologies for Industry 5.0 (STI)
language:
Short-container-title:

Author:

Hosen Md. Faruk¹,Yasmin Mst. Farjana¹,Basar Md. Abul²,Trisha Arifa Ferdoushi³,Shadhin Khairul Alam³,Mollah Md. Sarwar¹,Uddin Muhammad Shahin⁴

Affiliation:

1. Daffodil International University (DIU),Department of Computing and Information System,Ashulia, Dhaka,Bangladesh

2. Green University of Bangladesh (GUB),Department of Computer Science and Engineering,Purbachal American City, Kanchon,Bangladesh,1460

3. Daffodil International University (DIU),Department of Software Engineering,Ashulia, Dhaka,Bangladesh

4. Mawlana Bhashani Science and Technology University,Department of Information and Communication Technology,Tangail,Bangladesh,1902

Publisher

IEEE

Link

http://xplorestaging.ieee.org/ielx7/10464389/10464391/10465149.pdf?arnumber=10465149

Reference10 articles.

1. Aspects of renal-pulmonary pathogenic replationships in chronic kidney disease and chronic pulmonary diseases-a less-known connection;Gluhovschi;Rom J Intern Med.,2014

2. Network-based transcriptomic analysis identifies the genetic effect of COVID-19 to chronic kidney disease patients: A bioinformatics approach

3. Pulmonary Hypertension in CKD

4. Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis

5. Clinician's Corner: Counseling Patients with Pulmonary Vascular Disease Traveling to High Altitude